Bullisch
$62.32
Szenariopreis
$73.640
-1.421 (-1.93%)Zum Schluss
Synchrony Financial is a consumer financial services company focused on delivering digitally enabled product suites. The Company provides a range of credit products through financing programs it has established with a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers. It offers private label, dual card, co-brand, and general-purpose credit cards, as well as short- and long-term installment loans, and savings products through Synchrony Bank (the Bank). The Company primarily manages its credit products through five sales platforms such as Home & Auto, Digital, Diversified & Value, Health & Wellness and Lifestyle. The Bank offers directly to retail, affinity relationships and commercial customers, a range of deposit products, including certificates of deposit, individual retirement accounts (IRAs), money market accounts, savings accounts and sweep and affinity deposits.
Synchrony Financial appears to be a good buy right now, especially after raising its earnings outlook to $9.50 per share, which indicates strong confidence in future performance. The current price is $73.64, and the forward P/E ratio is low at 6.67, suggesting the stock is undervalued compared to its earnings potential. However, the main risk is the recent downgrade in price targets by analysts, with JPMorgan lowering theirs from $78 to $74, reflecting concerns about economic pressures on consumers.
Morgan Stanley
$83
2026-10-12
Morgan Stanley
2026-10-12
Kursziel
$83
JPMorgan
$74
2026-10-12
JPMorgan
2026-10-12
Kursziel
$74
BMO Capital
$81
2026-10-08
BMO Capital
2026-10-08
Kursziel
$81
Seaport Research
$93
2026-10-07
Seaport Research
2026-10-07
Kursziel
$93
TD Cowen
$86
2026-10-06
TD Cowen
2026-10-06
Kursziel
$86
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Federal Reserve's Upcoming Rate Decision Sparks Market Reactions

Synchrony Raises 2026 Earnings Outlook to $9.50 per Share

Monday Market Update from CNBC Investing Club

Strong Outlook for Q3 Earnings Season Amid Market Caution

CareCredit Partners with Vetspire for Enhanced Veterinary Financing
Synchrony Financial is a consumer financial services company focused on delivering digitally enabled product suites. The Company provides a range of credit products through financing programs it has established with a diverse group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations and healthcare service providers. It offers private label, dual card, co-brand, and general-purpose credit cards, as well as short- and long-term installment loans, and savings products through Synchrony Bank (the Bank). The Company primarily manages its credit products through five sales platforms such as Home & Auto, Digital, Diversified & Value, Health & Wellness and Lifestyle. The Bank offers directly to retail, affinity relationships and commercial customers, a range of deposit products, including certificates of deposit, individual retirement accounts (IRAs), money market accounts, savings accounts and sweep and affinity deposits. It operates in the Financials sector (FINANCE SERVICES industry).
Synchrony Financial appears to be a good buy right now, especially after raising its earnings outlook to $9.50 per share, which indicates strong confidence in future performance. The current price is $73.64, and the forward P/E ratio is low at 6.67, suggesting the stock is undervalued compared to its earnings potential. However, the main risk is the recent downgrade in price targets by analysts, with JPMorgan lowering theirs from $78 to $74, reflecting concerns about economic pressures on consumers.
21 analysts cover SYF: 15 rate it Buy, 6 Hold and 0 Sell. The average price target is 94.60.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.